Read From President IBC 2023

It gives me great pleasure to invite you to join us at the 1st International Biosimilars Congress, which will be held in Dubai (UAE) on 15th and 16th of September, 2023. The Congress offers a unique opportunity to attend a highly educational and comprehensive program for all the stakeholders involved in approving and using the biosimilars such as physicians, nurses, patients, and payors.

Through our experts, we shall tackle various hot topics related to biosimilars in Rheumatology, Hemato-Oncology, Oncology, Hematology, Dermatology and Gastroenterology in the Gulf and MENA regions. One of the main discussions will be about biosimilars implementation in medical specialities, biosimilars and healthcare sustainability, and regulatory approvals of biosimilars. International and regional recommendations on the use of biosimilars will be also discussed. Furthermore, practical workshops related to biosimilars will be part of the program.

Our goal is to engage physicians, nurses, pharmacists, regulators, and payors in the program.

We hereby invite you all to share your research studies by submitting abstracts related to biosimilars and becoming a part of the Congress, which will provide ample opportunities to grow within your specialty.

Dr. Khalid Alnaqbi

Dr. Khalid Alnaqbi
Congress Chairman
Consultant Rheumatologist
Adjust Associate Professor, UAE University